Counterfeit Innovation Puts Lives—and Markets—at Risk

President Donald Trump announced that his administration has reached agreements with drugmakers Eli Lilly and Novo Nordisk that would lower the price of some GLP-1 weight loss medications. (Photo by Andrew Harnik/Getty Images)

Getty…